| MIC (μM) for the following compounds | QC Drug μM, (μg/mL) | No. (%) AMCs w/ MICs ≤25 μMf | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Organism | 4f | 10 | 11f | 12 | 14 | 15 | 19 | 20 | 21 | Enrofloxacin | Â |
M. alligatoris | > 12.5 | > 25 | > 12.5 | 25 | > 25 | > 25 | > 25 | 18.8a | 25 | 0.17, (0.06) | 3 (33.3) |
M. agassizii | > 12.5 | > 25 | > 12.5 | > 25 | > 25 | 25 | > 25 | > 25 | 18.8a | 0.04–0.17, (0.02–0.06) | 2 (22.2) |
M. canis | > 12.5b | > 25 | > 12.5b | > 25 | > 25 | > 25 | > 25b | > 25d | 12.5a | 0.17–0.35, (0.06–0.13) | 1 (11.1) |
M. capricolum | > 12.5 | > 25 | > 12.5 | 12.5 | > 25 | > 25 | 25 | 12.5 | 25 | 0.4–0.7, (0.13–0.25) | 4 (44.4) |
M. gallisepticum | > 12.5 | > 25 | > 12.5 | 6.25a | > 25 | > 25 | > 25 | 18.8a | 12.5 | 0.04, (0.016)e | 3 (33.3) |
M. pulmonisc | > 12.5 | 12.5 | 12.5 | 12.5a | 12.5 | > 25 | > 25 | > 25 | 12.5a | 0.17–0.35, (0.06–0.13) | 5 (55.5) |
No. (%) AMCs with MICs ≤25 μMf | 0 | 1(16.7) | 1 (16.7) | 4 (66.7) | 1 (16.7) | 1 (16.7) | 1 (16.7) | 3 (50) | 6 (100) |